We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen Says Doctors Reevaluating Initiation of ESA Therapy
Amgen Says Doctors Reevaluating Initiation of ESA Therapy
April 24, 2007
Physicians are reevaluating when to initiate therapy with erythropoiesis-stimulating agents (ESAs), Amgen announced during its first-quarter earnings call.